Effects of basic fibroblast growth factor on endothelial cells under conditions of simulated microgravity

Journal of Cellular Biochemistry

Volumn 104, Issue 4, 2008, Pages 1324-1341

  Ulbricht, Claudia ^a   Westphal, Kriss ^a   Baatout, Sarah ^b   Wehland, Markus ^a   Bauer, Johann ^c   Flick, Burkhard ^a   Infanger, Manfred ^a   Kreutz, Reinhold ^a   Vadrucci, Sonia ^d   Egli, Marcel ^d   Cogoli, Augusto ^d   Derradji, Hanane ^b   Pietsch, Jessica ^a   Paul, Martin ^a   Grimm, Daniela ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d ETH ZURICH   (Switzerland)

Author keywords

Apoptosis; Basic fibroblast growth factor; Cytokines; NFkappaB

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 5; MESSENGER RNA; NUCLEAR FACTOR KAPPA B P50; PROTEIN BAX; SCLEROPROTEIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROGRAVITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

APOPTOSIS; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE SYNTHASE TYPE III; TRANSCRIPTION FACTOR RELA; WEIGHTLESSNESS;

EID: 46949085121     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21710     Document Type: Article

References (51)

1. Aird WC. 2005. Spatial and temporal dynamics of the endothelium. J Thromb Haemost 3:1392-1406.
2. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. 1995. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92:365-371.
3. Buravkova L, Romanov Y, Rykova M, Grigorieva O, Merzlikina N. 2005. Cell-to-cell interactions in changed gravity: Ground-based and flight experiments. Acta Astronautica 57:67-74.
4. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M. 1992. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267:19027-19030.
5. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. 1992. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991.
6. Desgranges P, Tardieu M, Loisance D, Barritault D. 1992. Extracellular matrix covered biomaterials for human endothelial cell growth. Int J Artif Organs 15:722-726.
7. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
8. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB. 1989. Role of extracellular matrix in the action of basic fibroblast growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 140:75-81.
9. Florkiewicz RZ, Sommer A. 1989. Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 86:3978-3981.
10. Fries RE, Maciag T. 1995. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J 9:919-925.
11. Ghosh S, May MJ, Kopp EB. 1998. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
12. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. 1987. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8:95-114.
13. Gougos A, St Jacques S, Greaves A, O'Connell PJ, d'Apice AJ, Buhring HJ, Bernabeu C, van Mourik JA, Letarte M. 1992. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4:83-92.
14. Grassl GA, Fessele S, Merfort I, Lindenmeyer MT, Castro V, Murillo R, Nelson PJ, Autenrieth IB. 2005. Sesquiterpene lactones inhibit Yersinia invasin protein-induced IL-8 and MCP-1 production in epithelial cells. Int J Med Microbiol 295:531-538.
15. Grimm D, Bauer J, Kossmehl P, Shakibaei M, Schonberger J, Pickenhahn H, Schulze-Tanzil G, Vetter R, Eilles C, Paul M, Cogoli A. 2002. Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells. FASEB J 16:55-81.
16. Grimm T, Schneider S, Naschberger E, Huber J, Guenzi E, Kieser A, Reitmeir P, Schulz TF, Morris CA, Sturzl M. 2005. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of Bax. Blood 105:3263-3269.
17. Grimm D, Bauer J, Infanger M, Cogoli A. 2006. The use of the random positioning machine for the study of gravitational effects on signal transduction in mammalian cells. Signal Transduct 6:388-396.
18. Hammond TG, Benes E, O'Reilly KC, Wolf DA, Linnehan RM, Taher A, Kaysen JH, Allen PI, Goodwin TJ. 2000. Mechanical culture conditions effect gene expression: Gravity induced changes on the space shuttle. Physiol Genomics 3:163-173.
19. Hoson T, Kamisaka S, Masuda Y, Yamashita M. 1992. Changes in plant growth processes under microgravity conditions simulated by a three-dimensional clinostat. Bot Mag 105:53-70.
20. Hughes-Fulford M, Sugano E, Schopper T, Li CF, Boonyaratanakornkit JB, Cogoli A. 2005. Early immune response and regulation of IL2 receptor subunits. Cell Signal 17:1111-1124.
21. Infanger M, Kossmehl P, Shakibaei M, Cogoli A, Witzing A, Faramarzi S, Wittfoht W, Paul M, Grimm D. 2004. Vascular endothelial growth factor inhibits programmed cell death of endothelial cells induced by clinorotation. J Gravit Physiol 11:199-200.
22. Infanger M, Kossmehl P, Shakibaei M, Baatout S, Witzing A, Grosse J, Bauer J, Cogoli A, Faramarzi S, Derradji H, Neefs M, Paul M, Grimm D. 2006a. Induction of three-dimensional assembly and increase in apoptosis of human endothelial cells by simulated microgravity: Impact of vascular endothelial growth factor. Apoptosis 11:749-764.
23. Infanger M, Kossmehl P, Shakibaei M, Bauer J, Kossmehl-Zorn S, Cogoli A, Curcio F, Oksche A, Wehland M, Kreutz R, Paul M, Grimm D. 2006b. Simulated weightlessness changes the cytoskeleton and extracellular matrix proteins in papillary thyroid carcinoma cells. Cell Tissue Res 324:267-277.
24. Infanger M, Faramarzi S, Grosse J, Kurth E, Ulbrich C, Bauer J, Wehland M, Kreutz R, Kossmehl P, Paul M, Grimm D. 2007a. Expression of vascular endothelial growth factor and receptor tyrosine kinases in cardiac ischemia/reperfusion injury. Cardiovasc Pathol 16:291-299.
25. Infanger M, Ulbrich C, Baatout S, Wehland M, Kreutz R, Bauer J, Grosse J, Vadrucci S, Cogoli A, Derradji H, Neefs M, Kusters S, Spain M, Paul M, Grimm D. 2007b. Modeled gravitational unloading induced downregulation of endothelin-1 in human endothelial cells. J Cell Biochem 101:1439-1455.
26. Izevbigie EB, Gutkind JS, Ray PE. 2000. Isoproterenol inhibits fibroblast growth factor-2-induced growth of renal epithelial cells. Pediat Nephrol 14:726-734.
27. Jin ZG, Ueba H, Tanimoto T, Lungu AO, Frame MD, Berk BC. 2003. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res 93:354-363.
28. Kofler S, Nickel T, Weis M. 2005. Role of cytokines in cardiovascular diseases: A focus in endothelial responses to inflammation. Clin Sci 108:205-213.
29. Kossmehl P, Shakibaei M, Cogoli A, Infanger M, Curcio F, Schonberger J, Eilles C, Bauer J, Pickenhahn H, Schulze-Tanzil G, Paul M, Grimm D. 2003. Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology 144:4172-4179.
30. Kossmehl P, Schonberger J, Shakibaei M, Faramarzi S, Kurth E, Habighorst B, von Bauer R, Wehland M, Kreutz R, Infanger M, Schulze-Tanzil G, Paul M, Grimm D. 2005. Increase of fibronectin and osteopontin in porcine hearts following ischemia and reperfusion. J Mol Med 83:626-637.
31. Lee BH, Park SY, Kang KB, Park RW, Kim IS. 2002. NF-kappa B activates fibronectin gene expression in rat hepatocytes. Biochem Biophys Res Commun 297:1218-1224.
32. Lewis ML, Cubano LA, Zhao BT, Dinh HK, Pabalan JG, Piepmeier EH, Bowman PD. 2001. cDNA microarray reveals altered cytoskeletal gene expression in space-flown leukemic T lymphocytes (Jurkat). FASEB J 15:1783-1785.
33. Li Q, Verma IM. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734.
34. Meuillet E, Cremel G, Hicks D, Dreyfus H. 1996. Ganglioside effects on basic fibroblast and epidermal growth factor receptors in retinal glial cells. J Lipid Mediat Cell Signal 14:277-288.
35. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846.
36. Miyazawa K, Mori A, Yamamoto K, Okudaira H. 1998. Transcriptional roles of CCAAT/Enhancer binding protein, nuclear factor-B, and C-promoter binding factor 1 in Interleukin (IL)-1-induced IL-6 synthesis by human rheumatoid fibroblast-like synoviocytes. J Biol Chem 273:7620-7627.
37. Numakawa T, Yokomaku D, Kiyosue K, Adachi N, Matsumoto T, Numakawa Y, Taguchi T, Hatanaka H, Yamada M. 2002. Basic fibroblast growth factor evokes a rapid glutamate release through activation of the MAPK pathway in cultured cortical neurons. J Biol Chem 277:28861-28869.
38. Pahl HL. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853-6866.
39. Pardo SJ, Patel MJ, Sykes MC, Piatt MO, Boyd NL, Sorescu GP, Xu M, van Loon JJWA, Wang MD, Jo H. 2005. Simulated microgravity using the Random Positioning Machine inhibits differentiation and alters gene expression profiles of 2T3 preosteoblasts. Am J Physiol Cell Physiol 288:C1211-C1221.
40. Pepper MS, Wasi S, Ferrara N, Orci L, Montesano R. 1994. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 210:298-305.
41. Sangha DS, Han S, Purdy RE. 2001. Simulated microgravity upregulates an endothelial vasoconstrictor prostaglandin. J Appl Physiol 91:789-796.
42. Schiffrin EL. 1994. The endothelium and control of blood-vessel function in health and disease. Clin Invest Med 17:602-620.
43. Senftleben U, Karin M. 2002. The IKK/NF-kappaB pathway. Crit Care Med 30:18-26.
44. Sharefkin JB, Diamond SL, Eskin SG, McIntire LV, Dieffenbach CW. 1991. Fluid-flow decreases preproendothelin messenger-RNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 14:1-9.
45. Takayama S, Yoshida J, Hirano H, Okada H, Murakami S. 2002. Effects of basic fibroblast growth factor on human gingival epithelial cells. J Periodontol 73:1467-1473.
46. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M. 2005. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96:684-692.
47. van Mourik JA, de Wit TR, Voorberg J. 2002. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 117:113-122.
48. Van Oost BA, Edgell CJS, Hay CW, MacGillivray RTA. 1986. Isolation of a human von Willebrand-factor cDNA from the hybrid endothelial-cell line EA.hy926. Biochem Cell Biol 64:699-705.
49. Veikkola T, Alitalo K. 1999. VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211-220.
50. Zhou P, Qian L, Kozopas KM, Craig RW. 1997. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89:630-643.
51. Ziegler T, Silacci P, Harrison VJ, Hayoz D. 1998. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32:351-355.